Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

  • This share is currently suspended. It was suspended at a price of 725.00
  • There is currently no data for AQX

Board Appointments

26 Apr 2022 15:05

RNS Number : 4137J
Aquis Exchange PLC
26 April 2022
Β 

26 April 2022

Aquis Exchange PLC

("Aquis", or the "Company")

Β 

Board Appointments

Β 

Further to the Company's announcement on 29 March 2022 and approval at the Annual General Meeting held earlier today, Aquis Exchange PLC (AQX.L, AQX.PL), the exchange services company,Β is pleased to announce that Richard Fisher has been appointed to the Board as Chief Financial Officer, and Dr. Ruth WandhΓΆfer and Fields Wicker-Miurin OBE have been appointed to the Board as Independent Non-Executive Directors, with immediate effect.

Β 

Richard Fisher first joined Aquis as Director of Finance in April 2021 and is based in London. Prior to joining Aquis, Richard was Director of Finance at Redwood Bank and other previous roles include Chief Accountant at RBS Group. Richard has assumed his duties as the Company's Chief Financial Officer following an orderly handover with current Chief Financial Officer, Jonathan Clelland. Jonathan will retain his roles as COO of the Group and CEO of Aquis Exchange Europe, and remain on the Board.

Β 

Dr. Ruth WandhΓΆfer joins Aquis alongside her duties as an independent Non-Executive Director at Permanent TSB, Digital Identity Net and Gresham Technologies. She also holds the role of Chair of the UK Payment Systems Regulator Panel. Ruth is a strategic adviser to the European Third-Party Payment Provider Association (ETPPA), a Partner at Gauss Ventures, member of the Advisory Board of RTGS.global and part-time CIO at GC Partners. Most recently she was an independent Non-Executive Director of the London Stock Exchange Group and Pendo Systems Inc. Furthermore, she has worked for the Commerzbank Real Estate Fund, the European Commission, the European Banking Federation and at Citi as Managing Director responsible at global level for the Regulatory & Market Strategy of the Treasury and Trade Solutions (TTS) business.

Fields Wicker-Miurin has a distinguished career with over 40 years' experience as an executive in financial services, a social entrepreneur focused on leadership, and a Non-Executive Director and committee chair of the boards of both global companies and government departments. From 1994-7 she led the transformation of the London Stock Exchange and the London equity markets while CFO and Strategy Director and from 2006-7 she was the only non-US member of the NASDAQ Technical Advisory Council. Fields was oneΒ of only 10 experts (and the only British one) advising the EU Parliament on financial services harmonisation in the lead-up to the Prospectus Directive.Β She currently serves as a Non-Executive Director and member and chair of key committees of the main boards of BNP Paribas (the eurozone's largest bank) and Scor (the world's 4th largest reinsurance company) andΒ is Deputy Chair of the Royal College of Art & Design.Β It is the intention, as part of the Company's succession planning process, that Fields will take over the Senior Independent Director role from Richard Bennett.

Commenting on the appointments Glenn Collinson, Chairman of Aquis Exchange PLC, said:

"We are delighted to announce the three new appointments to the Board, bringing a huge wealth of knowledge and experience to the leadership team, and helping us to drive forward towards our ambitious targets.

Β 

Richard has been a highly effective Director of Finance at Aquis over the past year, showing strong leadership and expertise. He has gathered considerable experience of the Company since joining which will put him in good stead for his new role as CFO. We are also very pleased to have Jonathan stay on the Board in the key roles of COO and CEO of Aquis Exchange Europe.

Β 

With Ruth and Fields, we have found people with incredibly impressive careers in financial services. Their highly regarded reputations within the banking industry and with regulators, alongside their expansive experience within the sector will help to drive continued success for the business."

Β 

Disclosure required pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies

The names of all companies and partnerships of which Richard John Fisher, aged 49, has been a director or partner at any time in the previous five years are set out below:

Current directorships or partnerships:

Previous directorships or partnerships:

None

National Westminster International Holdings B.V.

RBS AA Holdings (UK) Limited

Mr Fisher holds no ordinary shares in Aquis.

Save as set out in this announcement, there are no further details to be disclosed under Rule 17 or Schedule 2(g) of the AIM Rules for Companies in respect of Mr Fisher.

The names of all companies and partnerships of which Dr. Ruth WandhΓΆfer, aged 46, has been a director or partner at any time in the previous five years are set out below:

Current directorships or partnerships:

Previous directorships or partnerships:

Gresham Technologies PLC

London Stock Exchange Group PLC

Sinonyx Limited

Pendo Systems, Inc

Digital Identity Net U.K. Limited

Permanent Tsb Public Limited Company

Permanent Tsb Group Holdings Public Limited

Leximar Limited

Dr. WandhΓΆfer holds no ordinary shares in Aquis.

Save as set out in this announcement, there are no further details to be disclosed under Rule 17 or Schedule 2(g) of the AIM Rules for Companies in respect of Dr. WandhΓΆfer.

The names of all companies and partnerships of which Jane Fields Wicker-Miurin OBE, aged 63, has been a director or partner at any time in the previous five years are set out below:

Β 

Current directorships or partnerships:

Previous directorships or partnerships:

BNP Paribas S.A.

Prudential Public Limited Company

SCOR SE

SCOR UK Company Limited

Fields holds no ordinary shares in Aquis.

Save as set out in this announcement, there are no further details to be disclosed under Rule 17 or Schedule 2(g) of the AIM Rules for Companies in respect of Fields Wicker-Miurin OBE.

Β 

Enquiries:

Aquis Exchange PLC via

Alma PR (Financial PR Adviser):

Susie Hudson

Kieran Breheny

Β 

Tel: +44 (0)20 3405 0209

aquis@almapr.co.uk

Β 

VSA Capital Limited (AQSE Corporate Adviser)

Andrew Raca

Pascal Wiese

Β 

Liberum Capital Limited (Nominated Adviser and Joint Broker)

Chris Clarke

Clayton Bush

Edward Thomas

Β 

Tel: +44(0)20 3005 5000

Β 

Β 

Β 

Tel: +44 (0) 20 3100 2000

Canaccord Genuity Limited (Joint Broker)

Bobbie Hilliam

Patrick Dolaghan

Tel: +44 (0) 20 7523 8000

Β 

Β 

Notes to Editors

About Aquis Exchange PLC

Aquis Exchange PLC and its subsidiaries are an exchange services group which operate a pan-European cash equities trading businesses (Aquis Exchange), a growth and regulated primary market (Aquis Stock Exchange/AQSE) and develop/license exchange software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's AutoritΓ© des MarchΓ©s Financiers to operate Multilateral Trading Facility businesses in the UK/Switzerland and in EU27 respectively. Aquis Exchange operates lit and dark order books, covering 16 European markets. For its lit books, Aquis Exchange uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade and does not allow aggressive non-client proprietary trading, which has resulted in lower market impact and signalling risk on Aquis Exchange than other trading venues in Europe.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC is listed on the Aquis Stock Exchange and on the Alternative Investment Market of the LSE (AIM) market. For more information, please go toΒ www.aquis.eu.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NEXBSGDSXGDDGDL
Date   Source Headline
4th Apr 20227:00 amRNSDirector/PDMR Dealing
1st Apr 20223:53 pmRNSTransfer of UBS MTF Business Activities Completed
30th Mar 20229:35 amRNSExercise of Share Options and Total Voting Rights
29th Mar 20227:10 amRNSFinal Results and Board Appointments
29th Mar 20227:00 amRNSAdmission to Trading on the AQSE Growth Market
16th Mar 20227:00 amRNSTransfer of UBS MTF business activities to Aquis
11th Mar 20227:00 amRNSIntention to Dual List on the AQSE
24th Feb 20227:00 amRNSNotice of Results
8th Feb 20227:00 amRNSAquis Technologies partners with Investre
26th Nov 20219:48 amRNSExercise of Share Options and Total Voting Rights
26th Nov 20217:00 amRNSAppointment of New Chair
25th Nov 20217:00 amRNSDirector/PDMR Notification
23rd Sep 20215:39 pmRNSExercise of Share Options, Director Dealing & TVR
23rd Sep 20217:00 amRNSInterim Results
17th Sep 20217:00 amRNSBoard Appointment
1st Sep 20217:00 amRNSNotice of Results
25th Aug 20217:00 amRNSAppointment of independent NED to AQSE Board
2nd Aug 20217:00 amRNSAquis Exchange achieves record market share
28th Jun 20214:21 pmRNSExercise of Share Options and Director Dealing
27th May 20217:00 amRNSAQSE expands research for its top-tier stocks
18th May 20217:00 amRNSDual quotations with the Frankfurt Stock Exchange
13th May 20217:00 amRNSNew Senior Management Appointments
30th Apr 20217:00 amRNSDirector/PDMR Notification & Issue of Options
27th Apr 202112:41 pmRNSResult of Annual General Meeting
8th Apr 20217:00 amRNSDirector/PDMR Notification
31st Mar 20214:51 pmRNSPublication of ARA and Notice of AGM
31st Mar 20217:00 amRNSFinal Results
26th Mar 20217:00 amRNSNotice of Results
24th Mar 20217:00 amRNSAquis Exchange and ShareSoc Retail Investor Survey
26th Feb 20217:00 amRNSTrading and Operational Update
5th Feb 202112:07 pmRNSAppointment of Joint Broker
4th Feb 20218:03 amRNSAquis Exchange recommences trading in Swiss shares
14th Dec 20207:00 amRNSAQSE rule changes & market segments now in effect
26th Nov 20207:00 amRNSDirector/PDMR Notification
23rd Nov 20207:00 amRNSAQSE launches Market Maker Incentive Scheme
20th Nov 20202:00 pmRNSAquis works with SGX & AWS on cloud deployment
19th Oct 20207:00 amRNSAppointment to the AQSE Board
12th Oct 20207:00 amRNSAppointment of Independent Non-executive Director
9th Sep 20207:00 amRNSInterim Results
27th Aug 20207:00 amRNSNotice of Results
17th Jun 20207:00 amRNSBoard Appointment
16th Jun 20207:00 amRNSHolding(s) in Company
15th Jun 20207:01 amRNSDirector/PDMR Notification
15th Jun 20207:00 amRNSIssue of Options and Director/PDMR Notification
19th May 20201:26 pmRNSResult of Annual General Meeting
24th Apr 20207:00 amRNSPublication of ARA and Notice of AGM
20th Apr 20207:00 amRNSIssue of Options and Director/PDMR Notification
16th Apr 20207:00 amRNSFinal results
15th Apr 20207:00 amRNSExercise of Share Options & Total Voting Rights
24th Mar 20207:00 amRNSUpdate to Results Announcement Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.